MTHFR rs1801134: Understanding the c.1793G>A Variant
The rs1801134 variant is a single-nucleotide polymorphism in the human MTHFR gene, resulting in a missense coding change (c.1793G>A, p.Arg594Gln). While primary variants like C677T and A1298C are widely recognized modifiers of folate processing, rs1801134 has been evaluated alongside them for potential effects on homocysteine metabolism and health outcomes. Current scientific evidence regarding its independent biological and clinical significance remains limited.
What each genotype means
Typical enzyme baseline
You carry two copies of the reference G allele, which encodes the standard arginine amino acid at residue 594 of the MTHFR enzyme. Published biochemical and observational studies evaluate this genotype as the typical baseline, showing no alteration in enzyme kinetics or folate metabolism attributable to this locus. If you are reviewing overall folate pathway efficiency, established clinical guidelines recommend focusing on confirmed lifestyle factors and major primary variants rather than this site alone.
Carried by approximately 85% to 94% of people of European ancestry and the vast majority of non-European populations.
Mildly altered enzyme activity
You carry one copy of the A minor allele (also historically described as 1793A or Arg594Gln), which introduces an amino acid change in the regulatory domain of the MTHFR enzyme. In vitro research shows a modest decrease in baseline enzyme activity, but epidemiological studies report mixed or negligible effects on resting plasma homocysteine levels on its own. Evidence for any direct clinical risk or medication alteration remains limited and unproven, so no individual medical actions or prescription changes are warranted based on this genotype alone.
Carried by roughly 6% to 15% of individuals of European ancestry; it occurs at much lower frequencies in African and East Asian populations.
Modestly reduced enzyme activity
You carry two copies of the A minor allele, which causes an arginine-to-glutamine substitution at position 594 of the MTHFR protein. Experimental assays indicate this variant leads to reduced enzyme activity, yet published human clinical data remain very limited regarding significant standalone effects on hyperhomocysteinemia or disease susceptibility. Major clinical genetics guidelines do not consider this genotype diagnostic of a metabolic disorder; always consult a physician or pharmacist before considering dietary supplements or medication adjustments.
Very rare, observed in less than 1% of European populations and virtually absent in many other global ancestries.
Genomic Location and Variant Classification
The single-nucleotide polymorphism rs1801134 is located on chromosome 1 within the coding region of the MTHFR gene. At the molecular transcript level, the variant corresponds to cDNA position 1793, where a guanine is substituted by an adenine (c.1793G>A). This single base alteration changes codon 594 from arginine to glutamine (p.Arg594Gln) in the translated protein sequence. In genetic testing and reference catalogs such as dbSNP, it is tracked as a missense variant. Unlike canonical severe loss-of-function mutations associated with inborn errors of metabolism, rs1801134 represents a low-frequency natural coding variation within human populations.
The Role of the MTHFR Enzyme in Metabolism
The MTHFR gene encodes methylenetetrahydrofolate reductase, a key enzyme involved in the cytoplasmic folate cycle. This enzyme catalyzes the conversion of 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate, the predominant circulating form of folate needed for cellular health. 5-Methyltetrahydrofolate provides the essential methyl group required to convert homocysteine back into the amino acid methionine. Through this pathway, MTHFR activity is central to DNA synthesis, cellular repair, and the maintenance of normal blood homocysteine concentrations. Genetic variants that decrease enzyme stability or activity can potentially alter the efficiency of these downstream biochemical reactions.
Research Findings and Evidence Strength
Scientific research on rs1801134 is classified as having limited evidence regarding meaningful clinical outcomes. Much of the literature investigates this polymorphism in combination with more prominent MTHFR alleles, notably rs1801133 (C677T) and rs1801131 (A1298C). Certain exploratory association studies have examined whether the 1793A allele contributes incrementally to elevated homocysteine concentrations or obstetric complications such as recurrent pregnancy loss. However, study findings are inconsistent across different cohorts, and large-scale meta-analyses and genome-wide association studies do not support rs1801134 as an independent primary driver of disease. Clinically, evidence remains insufficient to establish clear disease predisposition.
How Common Is rs1801134?
According to genomic population databases, the minor 'A' allele of rs1801134 is observed at relatively modest frequencies globally. In European-ancestry populations, the minor allele frequency typically ranges between 3% and 8%, with a corresponding heterozygous genotype frequency of roughly 6% to 15%. Homozygosity for the alternate allele (AA) is rare, appearing in less than 1% of sampled European individuals. In many East Asian, African, and indigenous continental populations, the variant allele occurs at even lower frequencies or is near absent. This uneven distribution highlights the importance of ancestry-informed interpretation in genetic epidemiological studies.
Navigating Your Genetic Information
Identifying an rs1801134 variant in personal genomic raw data should not be interpreted as a medical diagnosis or a marker of disease. Standard dietary guidelines, such as obtaining adequate folate or folic acid through nutrient-dense foods or standard supplementation, are broadly protective irrespective of single MTHFR alleles. Because common variations in MTHFR do not prevent the body from utilizing standard forms of folate, self-directed medical decisions or extreme dietary interventions are not recommended. Anyone with specific concerns about folate status, elevated homocysteine, or medication safety should discuss comprehensive lab testing and personalized guidance directly with a qualified healthcare provider.
How common is this variant?
The minor A allele is observed at a frequency of approximately 0.03 to 0.08 in European ancestries, with the GA genotype present in about 6% to 15% of individuals, while the variant is considerably rarer across African and East Asian populations.
Frequently asked questions
What does the MTHFR rs1801134 variant mean?
The rs1801134 variant is a natural change in the MTHFR gene, alternating codon 594 from arginine to glutamine. It is considered a minor variant, and published research indicates that it has limited and inconclusive independent effects on overall health or folate metabolism.
Does rs1801134 cause high homocysteine levels?
Current scientific literature does not support rs1801134 as a major independent cause of hyperhomocysteinemia. While some small studies have evaluated it as part of compound haplotypes with other MTHFR variants, standard lifestyle, diet, and canonical variants like C677T exert a far greater biological impact.
Should I avoid folic acid if I carry the rs1801134 variant?
No. Authoritative public health bodies like the CDC emphasize that individuals with MTHFR variants can successfully metabolize all forms of folate, including folic acid. Standard fortified foods and prenatal folic acid supplementation remain safe, effective, and recommended.
Can I use rs1801134 to adjust my medications?
No, genetic variants should never be used independently to modify prescription dosages or discontinue medications. If you have questions about drug interactions, methotrexate therapy, or folate supplementation, discuss these results with your physician or pharmacist.
Sources & further reading
Educational information only, last refreshed 9/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1801134?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29